Burning Rock Biotech Ltd (BNR)

Nasdaq · Services-Medical Laboratories

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 3 signals for Burning Rock Biotech Ltd. Most notable: 2026-06-24: Han Yusheng (director) bought $2.0M of stock; 2026-06-22: Han Yusheng (director) bought $780k of stock; 2026-06-26: Han Yusheng (director) bought $199k of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Insider purchase
    Han Yusheng (director) bought $199k of stock
  2. Insider purchase
    Han Yusheng (director) bought $2.0M of stock
  3. Insider purchase
    Han Yusheng (director) bought $780k of stock
  4. Insider purchase
    Han Yusheng (director) bought $1000k of stock
  5. Insider purchase
    Han Yusheng (director) bought $1.9M of stock
  6. Insider purchase
    Han Yusheng (director) bought $216k of stock
  7. Insider purchase
    Han Yusheng (director) bought $5.5M of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-06-26Han YushengdirectorP24,9008$199,090
2026-06-24Han YushengdirectorP250,0008$2,000,000
2026-06-23Han YushengdirectorP5,9907.5$44,920
2026-06-22Han YushengdirectorP104,6507.45$779,674
2026-06-16Han YushengdirectorP111,1109$999,957
2026-06-12Han YushengdirectorP210,0009.25$1,942,143
2026-06-11Han YushengdirectorP24,7608.74$216,388
2026-03-31Han YushengdirectorP314,87017.36$5,466,143
2026-03-31Han YushengdirectorP314,87017.36$5,466,143

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings